These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7051485)

  • 1. Mouse skin allograft model for study of pregraft blood transfusion.
    Maki T; Okazaki H; Wood ML; Monaco AP
    Transplant Proc; 1982 Jun; 14(2):394-6. PubMed ID: 7051485
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of blood transfusion on skin allograft survival in immunosuppressed mice.
    Okazaki H; Maki T; Wood ML; Monaco AP
    Transplant Proc; 1981 Mar; 13(1 Pt 1):515-7. PubMed ID: 7022884
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of pre-transplantation blood transfusion on skin graft survival in mice].
    Gończowski L; Turowski G
    Patol Pol; 1982; 33(3-4):245-50. PubMed ID: 6761634
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of posttransplant injection of peripheral blood lymphocytes on skin graft prolongation in mice treated with antilymphocyte serum (ALS) or ALS plus donor bone marrow.
    Gozzo JJ; Hartner WC; Monaco AP; De Fazio SR
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1409-10. PubMed ID: 3274341
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparative study of neonatal and adult skin transplants in mice.
    Kowolenko M; Gozzo JJ
    Transplantation; 1984 Jul; 38(1):84-6. PubMed ID: 6377617
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of posttransplant-administered peripheral blood lymphocytes for prolonging allograft survival in ALS-treated mice.
    Gozzo JJ; Monaco AP; De Fazio SR
    Transplant Proc; 1989 Feb; 21(1 Pt 1):269-70. PubMed ID: 2650116
    [No Abstract]   [Full Text] [Related]  

  • 7. Tumor-associated alien alloantigens of BALB/c tumors encoded by the MHC and by non-H-2 genes: a histogenetic study.
    Parmiani G; Ballinari D; Sensi ML
    J Immunol; 1980 Feb; 124(2):662-8. PubMed ID: 6153203
    [No Abstract]   [Full Text] [Related]  

  • 8. Models of specific unresponsiveness to tissue allografts in antilymphocyte serum (ALS) treated mice.
    Wood ML; Monaco AP
    Transplant Proc; 1978 Jun; 10(2):379-87. PubMed ID: 354127
    [No Abstract]   [Full Text] [Related]  

  • 9. Multiple nonspecific blood transfusions prolong skin allograft survival in immunosuppressed mice.
    Okazaki H; Maki T; Monaco AP
    Proc Clin Dial Transplant Forum; 1979; 9():230-3. PubMed ID: 399513
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance induction to skin allografts following intrathymic injection with donor-specific splenocytes in major histocompatibility complex class I, class I+MLS, and class I+II disparities.
    Ohzato H; Monaco AP
    Transplant Proc; 1993 Feb; 25(1 Pt 1):297-8. PubMed ID: 8438307
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion-induced skin allograft enhancement across an H-2 class-I mismatch is caused by a clonal deletion of donor-specific cytotoxic T-lymphocyte precursors within the allograft.
    van Twuyver E; Kast WM; Mooijaart RJ; Melief CJ; de Waal LP
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1169-70. PubMed ID: 2650087
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of the YC8 lymphoma growth by alloimmunization with normal cells.
    Parmiani G; Sensi ML
    Transplant Proc; 1981 Dec; 13(4):1906-9. PubMed ID: 7330975
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of a single transfusion of donor-specific and nonspecific blood on skin allograft survival in mice.
    Okazaki H; Maki T; Wood M; Monaco AP
    Transplantation; 1980 Dec; 30(6):421-4. PubMed ID: 7008289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of cyclosporine, donor-specific transfusion, and antilymphocyte serum suppression of skin, heart, and fetal pancreatic islet allograft rejection in mice.
    Mason A; Mottram PL; Mirisklavos A; Clurne GJ; Mandel TE
    Transplantation; 1988 Jun; 45(6):1155-7. PubMed ID: 3132766
    [No Abstract]   [Full Text] [Related]  

  • 15. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin.
    Dono K; Maki T; Wood ML; Monaco AP
    Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ability of syngeneic spleen cells coated with antilymphocyte antibodies in vitro to prolong the skin allograft survival in mice.
    Rudnicka W
    Bull Acad Pol Sci Biol; 1979; 27(12):1015-20. PubMed ID: 399869
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of skin allograft survival in H-2 K and I region-incompatible mice by pretransplant blood transfusion.
    Okazaki H; Maki T; Wood ML; Jones S; Monaco AP
    Transplantation; 1981 Aug; 32(2):111-5. PubMed ID: 7027546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pretransplant blood transfusion with cyclophosphamide: efficacious means of prolonging allograft survival.
    Lagodzinski Z; Gorski A
    Folia Biol (Praha); 1991; 37(1):21-6. PubMed ID: 2070885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
    Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
    Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic control of allograft tolerance: importance of H-2 subregions.
    Click RE; Cahill G; Condie RM; Azar MM; Najarian JS
    Transplant Proc; 1981 Mar; 13(1 Pt 1):582-5. PubMed ID: 7022894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.